June 6, 2019 Clinical Research/Diagn. M&A, Partnerships

bioMérieux increases its holding in Hybiome from 54% to 67%

06 June, 2019 bioMérieux, a world leader in the field of in vitro diagnostics, today announced an increase of its shareholding in Suzhou Hybiome Biomedical Engineering Co. Ltd. This announcement follows the earlier announcement of the acquisition of a majority stake in this company in November 2018. Founded in 2009 and located in Suzhou (China), Hybiome is specialized... Read more

November 9, 2018 Clinical Research/Diagn. M&A, Partnerships

bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market

09 November, 2018 bioMérieux, a world leader in the field of in vitro diagnostics, today announces the acquisition of a majority holding in Suzhou Hybiome Biomedical Engineering Co.Ltd. This announcement follows the acquisition of a minority stake in July 2018. Founded in 2009 and based in Suzhou (China), Hybiome is specialized in automated immunoassay tests. The... Read more